Press Release

Three major health groups today jointly recommended that healthcare
providers temporarily suspend routine use of the fourth dose of the
pneumococcal conjugate vaccine (PCV7). The Centers for Disease Control and
Prevention (CDC) Advisory Committee for Immunization Practices (ACIP), the
American Academy of Pediatrics (AAP) and the American Academy of Family
Physicians (AAFP) made the recommendation to conserve vaccine and minimize the
likelihood of shortages caused by production and supply problems at Wyeth
Vaccines, the only supplier of the vaccine in the United States.

We are taking this action to ensure that every child can be protected
against pneumococcal disease despite the limited supply, said Dr. Steve
Cochi, acting director for the CDC National Immunization Program.

The recommendation calls for the temporary suspension of the fourth dose
of PCV7, a booster dose given at 12 to 15 months of age. Healthcare
providers should move to a three-dose series of one dose at two months, one
dose at four months, and one dose at six months. Providers should continue
to administer the fourth dose to children at increased risk of severe
disease. Children whose booster dose is deferred should receive PCV7 on
their first visit after supplies return to normal. This recommendation is
not expected to have any adverse health consequences for children.

CDC estimates this action will help conserve more than 1 million doses by
July 2004, making widespread or prolonged disruptions less likely.

In November, 2003, CDC learned from the manufacturer that production
constraints could cause delays in shipment of the vaccine in early 2004.
Since then, CDC has worked closely with the manufacturer to continually
assess the situation and manage the allocation of limited supplies of PCV7
to ensure a balanced inventory across states and immunization programs.

The manufacturer has advised CDC that production problems have not been
resolved and supplies are likely to be limited through mid-summer or later.

The vaccine can help prevent serious pneumococcal disease such as
meningitis and blood infections. Invasive pnuemococcal disease is
responsible for about 200 deaths each year among children under five years
of age. It is the leading cause of bacterial meningitis in the United
States. Children under two years of age are at highest risk. Before a
vaccine was available, each year pneumococcal infection caused more than 700
cases of meningitis, 13,000 blood infections and about 5 million ear
infections.

# # #

CDC protects people's health and safety by preventing and
controlling diseases and injuries; enhances health decisions by providing
credible information on critical health issues; and promotes healthy living
through strong partnerships with local, national, and international
organizations.